Miltenyi Biomedicine
Dr. Sandra Karitzky has a extensive background in clinical operations and trial management, working in various leadership roles at Miltenyi Biomedicine and Miltenyi Biotec. With a strong focus on managing teams, optimizing processes, and ensuring compliance, Dr. Sandra has played key roles in the successful execution of clinical research portfolios. Dr. Karitzky holds a PhD in Immunology from the University of Tübingen and a Master's degree in Biochemistry from Martin Luther Universität Halle.
Miltenyi Biomedicine
2 followers
Miltenyi Biomedicine is a biopharmaceutical company that develops innovative cell and gene therapies. We are committed to bring cancer treatments and regenerative therapies to patients with unmet medical needs worldwide. We work in partnership with physicians and other healthcare providers to expand access to new therapies. Our clinical research program includes: CAR T, CAR NK, our proprietary Adapter CAR™ and induced pluripotent stem cells (iPSC) technologies. For more information, please visit our website at www.miltenyibiomedicine.com.